(Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that the company will host a ...
Company reports $14.3 million in revenue in Q3’25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license and ...
"We worked closely with Consumers Energy customers to make payment programs and savings options easier to find and use," said Brian Lewis, Consumers Energy's Senior Executive Director of Customer ...
FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...
Small, overlooked details can make or break a website’s success. Incorporating smart design choices quietly drives engagement ...
Lantern Pharma will host a conference call and webcast to discuss third quarter 2025 financial results and business updates on Thursday, November 13, 2025 at 9:00 a.m. Eastern Time.
Real victory will come when secure by design isn’t a special initiative but the standard starting point for every project.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback